Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs)
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Selective serotonin reuptake inhibitors are thought to have better discontinuation rates (i.e. less people dropping out) than tricyclic and heterocyclic antidepressant drugs. It is important to quantify the drop-out rates of different antidepressant drugs in order to have a better understanding of the relative tolerability of these drugs. OBJECTIVES: To assess the comparative tolerability of selective serotonin reuptake inhibitors and tricyclic/heterocyclic antidepressant drugs. SEARCH STRATEGY: We searched the Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials Registers (1997 to 1999), MEDLINE (1966 to 1999), EMBASE (1974 to 1999) We also searched specialist journals, the reference lists of relevant papers and previous systematic reviews, conference abstracts and government documents. Representatives of the pharmaceutical industry were contacted. SELECTION CRITERIA: Parallel group randomised controlled trials comparing selective serotonin reuptake inhibitors with tricyclic or heterocyclic antidepressants in people with depression. DATA COLLECTION AND ANALYSIS: Two reviewers independently extracted data and a third reviewer checked any cases of disagreement. MAIN RESULTS: We included 136 trials. The selective serotonin reuptake inhibitors showed less participants dropping out compared to the tricyclic/heterocyclic group (odds ratio 1.21, 95% confidence interval 1.12 to 1.30). A statistically significant difference was found in total drop-outs between the selective serotonin reuptake inhibitors and the old tricyclics as well as the newer tricyclics. When the selective serotonin reuptake inhibitors were compared to the heterocyclic antidepressants, there was a non significant difference favouring the selective serotonin reuptake inhibitors. The poor tolerability profile of the old tricyclics was explained by differences in drop-outs for side-effects, but not for inefficacy. AUTHORS' CONCLUSIONS: Whilst selective serotonin reuptake inhibitors do appear to show an advantage over tricyclic drugs in terms of total drop-outs, this advantage is relatively modest. This has implications for pharmaco-economic models, some of which may have overestimated the difference of drop-out rates between selective serotonin reuptake inhibitors and tricyclic antidepressants. These results are based on short-term randomised controlled trials, and may not generalise into clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trials to assess equivalence: the importance of rigorous methods: Fig 1
Jones, B., Jarvis, P., Lewis, J. A., & Ebbutt, A. F. (1996) · BMJ · doi:10.1136/bmj.313.7048.36 · Cited by 1,032
Recognition and management of depression in general practice: consensus statement
Paykel, E. S., & Priest, R. G. (1992) · BMJ · doi:10.1136/bmj.305.6863.1198 · Cited by 540
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399
Self-citationBollini, P., Pampaliona, S., Tibaldi, G., Kupelnick, B., & Munizza, C. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.174.4.297 · Cited by 274
The compliance with antidepressants in general practice
Maddox, J. C., Levi, M., & Thompson, C. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800108 · Cited by 148
Hotopf, M., Lewis, G., & Normand, C. (1997) · Journal of Epidemiology and Community Health · doi:10.1136/jech.51.4.354 · Cited by 130
Self-citationBYERLEY, W. F., REIMHERR, F. W., WOOD, D. R., & GROSSER, B. I. (1988) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198804000-00005 · Cited by 80
Rosenberg, C., Damsbo, N., Fuglum, E., Jacobsen, L. V., & Horsgård, S. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00007 · Cited by 58
TOLLEFSON, G. D., GREIST, J. H., JEFFERSON, J. W., HEILIGENSTEIN, J. H., SAYLER, M. E., TOLLEFSON, S. L., & KOBACK, K. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199412000-00003 · Cited by 47
Research works printed but not linked: 169
- Ahlfors, 1988, Clinical multicentre study of citalopram compared double-blindly with mianserin in depressed patients in Finland, Nord Psykiatr Tidsskr, 42, 201, 10.3109/08039488809094957 · DOI
- Altamura, 1989, Fluoxetine compared with amitriptyline in elderly depression: A controlled clinical trial, International Journal of Clinical Pharmacology Research, 9, 391
- Amin, 1984, Fluvoxamine: Antidepressant effects confirmed in a placebo-controlled international study, Clinical Neuropharmacology, 7, 580
- Amore, 1989, Double blind comparison of fluvoxamine and imipramine in depressed patients, Current Therapeutic Research, Clinical & Experimental, 46, 815
- Arminen, 1994, A 12-week double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients, Acta Psychiatrica Scandinavica, 89, 382, 10.1111/j.1600-0447.1994.tb01533.x · DOI
- Bascara, 1989, A double blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients, Acta Psychiatrica Scandinavica, 80, 141, 10.1111/j.1600-0447.1989.tb07196.x · DOI
- Battegay, 1985, Double-blind comparative study of paroxetine and amitriptyline in depressed patients of a university psychiatric outpatient clinic, Neuropsychobiology, 13, 31, 10.1159/000118159 · DOI
- Beasley, 1991, Fluoxetine versus trazodone: efficacy and activating side effects, Journal of Clinical Psychiatry, 52, 294
- Perry, 1989, A comparative trial of fluoxetine versus trazodone in outpatients with major depression, Journal of Clinical Psychiatry, 50, 290
- Beasley, 1993, Fluoxetine compared with imipramine in the treatment of inpatient depression: A multicentre trial, Annals of Clinical Psychiatry, 5, 199, 10.3109/10401239309148983 · DOI · Paper page
- Bersani, 1994, A double-blind comparative study of sertraline and amitriptyline in outpatients with major depressive episodes, Human Psychopharmacology, 9, 63, 10.1002/hup.470090108 · DOI
- Besancon, 1993, Double-blind study of mianserin and fluoxetine in ambulatory therapy of depressed patients, Encephale, 19, 341
- Bignamini, 1992, A double-blind multicentre study of paroxetine and amitriptyline in depressed outpatients, International Clinical Psychopharmacology, 6, 37, 10.1097/00004850-199206004-00008 · DOI · Paper page
- Bouchard, 1987, Citalopram versus maprotiline: A controlled, clinical multicentre trial in depressed patients, Acta Psychiatrica Scandinavica, 76, 583, 10.1111/j.1600-0447.1987.tb02923.x · DOI · Paper page
- Bowden, 1993, Fluoxetine and desipramine in major depressive disorder, Journal of Clinical Psychopharmacology, 13, 305, 10.1097/00004714-199310000-00002 · DOI · Paper page
- Bramanti, 1988, An Italian multicenter experience with fluvoxamine, a new antidepressant drug, versus imipramine, Current Therapeutic Research, Clinical & Experimental, 43, 718
- Bremner, 1984, Fluoxetine in depressed patients: a comparison with imipramine, Journal of Clinical Psychiatry, 45, 414
- Bressa, 1989, A double blind study of fluoxetine and imipramine in major depression, International Clinical Psychopharmacology, 4, 69
- Byrne, 1989, Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients, Acta Psychiatrica Scandinavica, 80, 138, 10.1111/j.1600-0447.1989.tb07194.x · DOI
- Chiu, 1996, Paroxetine in the treatment of Chinese patients with depressive episode: a double-blind randomized comparison with imipramine, Chung Hua I Hsueh Tsa Chih Taipei, 57, 418
- Chouinard, 1985, A double-blind controlled trial of fluoxetine and amitriptyline in the treatment of outpatients with major depression, Journal of Clinical Psychiatry, 46, 32
- Christiansen, 1996, Paroxetine and amitriptyline in the treatment of depression in general practice, Acta Psychiatrica Scandinavica, 93, 158, 10.1111/j.1600-0447.1996.tb10623.x · DOI
- Beasley, 1991, High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depression, Journal of Clinical Psychopharmacology, 11, 166, 10.1097/00004714-199106000-00004 · DOI · Paper page
- Cohn, 1985, A comparison of fluoxetine, imipramine and placebo in patients with major depressive disorder, Journal of Clinical Psychiatry, 46, 26
- Cohn, 1989, A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder, International Clinical Psychopharmacol, 4, 313, 10.1097/00004850-198910000-00006 · DOI · Paper page
- Cohn, 1990, Double-blind, mulitcenter comparison of sertraline and amitriptyline in elderly depressed patients, Journal of Clinical Psychiatry, 51, 28
- Cohn, A placebo- and imipramine controlled study of paroxetine, Psychopharmacology Bulletin, 26, 185
- Dalery, 1992, Comparative study of the efficacy and acceptability of amineptine and fluoxetine in patients with major depression, Encephale, 18, 257
- Christensen, 1985, Orthostatic side effects of clomipramine and citalopram during treatment for depression, Psychopharmacology, 86, 383, 10.1007/BF00427895 · DOI
- 1986, Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study, Psychopharmacology, 90, 131
- 1990, Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled mulitcenter study, Journal of Affective Disorder, 18, 289, 10.1016/0165-0327(90)90081-I · DOI · Paper page
- Jonghe, Randomized double-blind study of fluoxetine and maprotiline in the treatment of major depression, Pharmacopsychiatry, 24, 422
- Jonghe, A randomized, double blind study of fluvoxamine and maprotiline in treatment of depression, Pharmacopsychiatry, 24, 21, 10.1055/s-2007-1014428 · DOI
- Wilde, 1983, Clinical trials of fluvoxamine vs clomipramine with single and three times dosing, British Journal of Clinical Pharmacology, 15, 427, 10.1111/j.1365-2125.1983.tb02133.x · DOI
- Wilde, 1985, Citalopram versus mainserin: a controlled, double-blind trial in depressed patients, Acta Psychiatrica Scandinavica, 72, 89, 10.1111/j.1600-0447.1985.tb02576.x · DOI · Paper page
- Demyttenaere, 1998, Compliance in depressed patients treated with fluoxetine or amitriptyline, International Clinical Psychopharmacology, 13, 11, 10.1097/00004850-199801000-00002 · DOI · Paper page
- Dick, 1983, A double-blind comparative study on the efficacy of fluvoxamine and clomipramine, British Journal of Clinical Pharmacology, 15, 419, 10.1111/j.1365-2125.1983.tb02132.x · DOI · Paper page
- Dominguez, 1985, A double-blind, placebo controlled study of fluvoxamine and imipramine in depression, Journal of Clinical Psychiatry, 46, 84
- Doogan, 1994, A double-blind, placebo-controlled comparison of sertraline and dothiepin in the treatment of major depression in general practice, International Clinical Psychopharmacology, 9, 95, 10.1097/00004850-199400920-00005 · DOI · Paper page
- Dowling, 1990, Fluoxetine: a comparative study with dothiepin, Irish Journal of Psychiatry, 11, 3
- Dunner, 1992, Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patient with major depression, Journal of Clinicl Psychiatry, 53, 57
- Fabre, 1991, Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study, Journal of Clinical Psychiatry, 52, 62
- Fabre, 1996, Fluvoxamine versus imipramine and placebo: A double-blind comparison in depressed patients, International Clinical Psychopharmacology, 11, 119
- Falk, 1989, Fluoxetine versus trazodone in depressed geriatric patients, Journal of Geriatric Psychiatry & Neurology, 2, 208, 10.1177/089198878900200407 · DOI · Paper page
- Fawcett, 1989, Fluoxetine vs amitriptyline in adult inpatients with major depression, Current Therapeutic Research, Clinical & Experimental, 45, 821
- Feighner, 1985, Double-blind comparative study of fluoxetine and doxepin in geriatric patients with major depressive disorder, Journal of Clinical Psychiatry, 46, 20
- Feighner, 1985, A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder, Journal of Clinical Psychiatry, 46, 369
- Feighner, 1989, A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression, International Clinical Psychopharmacology, 4, 127, 10.1097/00004850-198904000-00004 · DOI · Paper page
- Feighner, A pacebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression, International Clinical Psychopharmacology, 4, 239, 10.1097/00004850-198907000-00006 · DOI · Paper page
- Feighner, 1991, Double-blind comparison of bupropion and fluoxetine in depressed outpatients, Journal of Clinical Psychiatry, 52, 229
- Dunbar, 1991, A comparison of paroxetine, imipramine and placebo in depressed out-patients, British Journal of Psychiatry, 159, 394, 10.1192/bjp.159.3.394 · DOI · Paper page
- Feighner, 1993, A study comparing paroxetine placebo and imipramine in depressed patients, Journal of Affective Disorders, 28, 71, 10.1016/0165-0327(93)90035-I · DOI
- Ferreri, 1989, Fluoxetine versus amipentine in the treatment of outpatients with major depressive disorder, International Clinical Psychopharmacology, 4, 97
- Fournier, 1997, A double-blind comparison of sertraline and imipramine in outpatients with major depression: Acute (8 weeks) and continuation (16 weeks) treatment, Human Psychopharmacology, 12, 203, 10.1002/(SICI)1099-1077(199705/06)12:3<203::AID-HUP849>3.0.CO;2-V · DOI
- Fudge, 1990, A comparison of the effect of fluoxetine and trazodone on the cognitive functioning of depressed outpatients, Journal of Affective Disorders, 18, 275, 10.1016/0165-0327(90)90079-N · DOI
- Gasperini, 1992, Perspectives in clinical psychopharmacology of amitriptyline and fluvoxamine, Neuropsychobiology, 26, 186, 10.1159/000118918 · DOI
- Geretsegger, 1995, Multicentre double-blind study of paroxetine and amitriptyline in elderly depressed inpatients, Psychopharmacology, 119, 277, 10.1007/BF02246291 · DOI
- Gonella, 1990, Fluvoxamine and imipramine in the treatment of depressive patients, Current Medical Research & Opinion, 12, 177, 10.1185/03007999009111499 · DOI · Paper page
- Gravem, 1987, A double-blind comparison of citalopram (Lu 10-171) and amitriptyline in depressed patients, Acta Psychiatrica Scandinavica, 75, 78, 10.1111/j.1600-0447.1987.tb02821.x · DOI · Paper page
- Guelfi, 1983, A double-blind controlled clinical trial comparing fluvoxamine with imipramine, British Journal of Clinical Pharmacology, 15, 411, 10.1111/j.1365-2125.1983.tb02131.x · DOI
- Guillibert, 1989, A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients, Acta Psychiatrica Scandinavica Supplementum, 350, 132, 10.1111/j.1600-0447.1989.tb07192.x · DOI
- Harris, 1991, Fluvoxamine versus amitriptyline in depressed hospital out-patients: a mulitcentre double blind comparative trial, British Journal of Clinical Research, 2, 89
- Hutchinson, 1992, Paroxetine in the treatment of elderly depressed patients in general practice: a double-blind comparison with amitriptyline, International Clinical Psychopharmacology, 6, 43, 10.1097/00004850-199206004-00009 · DOI · Paper page
- Itil, 1983, A double-blind placebo-controlled study of fluvoxamine and imipramine in outpatients with primary depression, British Journal of Clinical Pharmacology, 15, 433, 10.1111/j.1365-2125.1983.tb02134.x · DOI · Paper page
- Jakovljevic, 1996, Central-East European Study of fluoxetine (Portal, Lek) and maprotiline (Ladiomil, Pliva) in major depressive episode, Psychiatria Danubina, 8, 1
- Kamijima, 1997, Clinical evaluation of sertraline hydrochloride, a selective serotonin reuptake inhibitor in the treatment of depression and depressive state: A double-blind, group comparison study of sertraline by hydrochloride vs amitriptyline hydrochloride, Japanese Journal of Neuropsychopharmacology, 196, 529
- Kasper, 1990, Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study, Pharmacopsychiatry, 23, 135, 10.1055/s-2007-1014496 · DOI · Paper page
- Keegan, 1991, A comparison of fluoxetine and amitriptyline in the treatment of major depression, International Clinical Psychopharmacology, 6, 117, 10.1097/00004850-199100620-00007 · DOI · Paper page
- Keller, 1998, A double-blind, randomised trial of sertraline and imipramine, Journal of Clinical Psychiatry, 59, 598, 10.4088/JCP.v59n1107 · DOI · Paper page
- Klok, 1981, Fluvoxamine and clomipramine in depressed patients, Acta Psychiatrica Scandinavica, 64, 1, 10.1111/j.1600-0447.1981.tb00756.x · DOI
- Kuha, 1991, The efficacy of fluoxetine versus maprotiline in depressed patients and by dose, Nord Psychiatr Tidsskr, 45, 109
- Kuhs, 1989, A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline, Acta Psychiatr Scand suppl, 350, 145, 10.1111/j.1600-0447.1989.tb07198.x · DOI
- Kyle, 1998, Comparison of the tolerability and efficacy of citalopram and amitrptyline in elderly depressed patients treated in general practice, Depression & Anxiety, 8, 147, 10.1002/(SICI)1520-6394(1998)8:4<147::AID-DA3>3.0.CO;2-F · DOI · Paper page
- Pia, 1992, Double-blind controlled study to evaluate the effectiveness and tolerability of fluoxetine versus mianserin in the treatment of depressive disorders among the elderly and their effects on cognitive behavioural parameters, New Trends in Experimental & Clinical Psychiatry, 8, 139
- Laakmann, 1988, Fluoxetine vs amitriptyline in the treatment of depressed out-patients, British Journal of Psychiatry, 153, 64, 10.1192/S0007125000297316 · DOI · Paper page
- Laakmann, 1991, Selective re-uptake-hemmung und ihre bedeutung fur die depression, 10.1007/978-3-642-76137-9 · doi:10.1007/978-3-642-76137-9
- Lapierre, 1987, Treatment of major affective disorder with fluvoxamine, Journal of Clinical Psychiatry, 48, 65
- Laursen, 1985, Paroxetine in the treatment of depression - a randomised comparison with amitriptyline, Acta Psychiatrica Scandinavica, 71, 249, 10.1111/j.1600-0447.1985.tb01281.x · DOI · Paper page
- Levine, 1987, A comparative trial of a new antidepressant, fluoxetine, British Journal of Psychiatry, 150, 653, 10.1192/bjp.150.5.653 · DOI · Paper page
- Levine, 1989, A comparative trial of a new antidepressant, fluoxetine, International Clinical Psychopharmacology, 4, 41
- Link, 1992, An overview of studies comparing the efficacy, safety, and tolerability of paroxetine and clomipramine, Nordic Journal of Psychiatry, 46, 17, 10.3109/08039489209101156 · DOI
- Lydiard, 1989, Fluvoxamine, imipramine and placebo in the treatment of depressed outpatients: effects on depression, Psychopharmacology Bulletin, 25, 68
- Lydiard, 1997, A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression, Journal of Clinical Psychiatry, 58, 484, 10.4088/JCP.v58n1104 · DOI · Paper page
- March, 1990, A double blind, placebo-controlled study of fluvoxamine versus imipramine in outpatients with major depression, Journal of Clinical Psychiatry, 51, 200
- Beasley, 1993, Fluoxetine versus amitriptyline in the treatment of major depression: A multicenter trial, International Clinical Psychopharmacology, 8, 143, 10.1097/00004850-199300830-00002 · DOI · Paper page
- Masco, 1985, Double-blind comparison of fluoxetine and amitryptyline in the treatment of major depressive illness, Adv Ther, 2, 275
- Mertens, 1988, Paroxetine in the treament of depression. A double blind multicentre study versus mianserin, Acta Psychiatrica Scandinavica, 77, 683, 10.1111/j.1600-0447.1988.tb05188.x · DOI · Paper page
- Moller, 1993, Double-blind multicenter study of paroxetine and amitriptyline in depressed patients, Pharmacopsychiatry, 26, 75, 10.1055/s-2007-1014346 · DOI · Paper page
- Moller, 1998, Double-blind, multicenter comparative study of sertraline and amitriptyline in hospitalized patients with major depression, Pharmacopsychiatry, 31, 170, 10.1055/s-2007-979323 · DOI
- Moon, 1991, The effects of psychomotor performance of fluvoxamine versus mianserin in depressed patients in general practice, British Journal of Clinical Practice, 45, 259
- Moon, 1994, A double-blind comparison of sertraline and clomipramine in the treatment of major depressive disorder and associated anxiety in general practice, Journal of Psychopharmacology, 8, 171, 10.1177/026988119400800306 · DOI
- Moon, 1996, Treatment of major depression in general practice: A double-blind comparison of paroxetine and lofepramine, British Journal of Clinical Practice, 50, 240
- Muijen, 1988, A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients, Acta Psychiatrica Scandinavica, 78, 384, 10.1111/j.1600-0447.1988.tb06353.x · DOI · Paper page
- Mullin, 1994, A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder, British Journal of Clinical Practice, 42, 51
- Murasaki, 1997, Clinical evaluation of sertraline hydrochloride, a selective serotonin reuptake inhibitor for depression and depressive state-A double-blind study compared with imipramine hydrochloride, Japanese Journal of Neuropsychopharmacology, 19,, 505
- Nathan, 1990, The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine, Journal of Clinical Psychiatry, 51, 367
- Nielsen, 1991, Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements, Acta Psychiatrica Scandinavica, 84, 233, 10.1111/j.1600-0447.1991.tb03136.x · DOI
- Skausig, 1992, Paroxetine and imipramine treatment of depressed patients in a controlled, multicentre study with plasma amino acid measurements, Nord J Psychiatry, 46, 23, 10.3109/08039489209101157 · doi:10.3109/08039489209101157
- Nielsen, 1993, A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder, Acta Psychiatrica Scandinavica, 87, 269, 10.1111/j.1600-0447.1993.tb03370.x · DOI
- Noguera, 1991, Fluoxetine vs clomipramine in depressed patients: A controlled multi-centre trial, Journal of Affective Disorder, 22, 119, 10.1016/0165-0327(91)90045-T · DOI
- Norton, 1984, A double blind comparison of fluvoxamine, imipramine and placebo in depressed patients, Journal of Affective Disorders, 7, 297, 10.1016/0165-0327(84)90051-X · DOI
- Ohrberg, 1992, Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice, Acta Psychiatrica Scandinavica, 86, 437, 10.1111/j.1600-0447.1992.tb03294.x · DOI
- Ottevanger, 1995, Fluvoxamine and clomipramine in depressed hospitalised patients: Results from a randomised, double blind study, Encephale, 21, 317
- Pakesch, 1991, Efficacy and safety of fluoxetine versus clomipramine in ambulatory patients with a depressive syndrome in a clinical trial with private practitioners, Wiener klinische Wochenschrift, 103, 176
- Pelicier, 1993, Multicenter double-blind study comparing the efficacy and tolerance of paroxetine and clomipramine in reactive depression in the elderly patient, Encephale, 19, 257
- Peselow, 1989, The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo, Psychopharmacology Bulletin, 25, 267
- Peters, 1990, Therapy of depression in the psychiatrist's office - A double-blind multicenter study, Nervenheihunde, 9, 28
- Phanjoo, 1991, Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people, Acta Psychiatrica Scandinavica, 83, 476, 10.1111/j.1600-0447.1991.tb05579.x · DOI · Paper page
- Poelinger, 1989, Fluoxetine 40mg vs maprotiline 75mg in the treatment of outpatients with depressive disorders, International Clinical Psychopharmacology, 4, 47
- Preskorn, 1991, Antidepressant response and plasma concentrations of fluoxetine, Annals of Clinical Psychiatry, 3, 147, 10.3109/10401239109147984 · DOI
- Rahman, 1991, A double-blind, randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients, British Journal of Clinical Practice, 45, 255
- Ravindran, 1995, The impact of sertraline, desipramine, and placebo on psychomotor functioning in depression, Human Psychopharmacology, 10, 273, 10.1002/hup.470100404 · DOI · Paper page
- Ravindran, 1997, A double-blind, multicenter study in primary-care comparing paroxetine and clomipramine in patients with depression and associated anxiety, Journal of Clinical Psychiatry, 58, 112, 10.4088/JCP.v58n0305 · DOI · Paper page
- Reimherr, 1990, Antidepressant efficacy of sertraline: A double blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression, Journal of Clinical Psychiatry, 51, 18
- Remick, 1989, A comparison between fluoxetine and doxepin in depressed patients, Current Therapeutic Research, Research & Experimental, 46, 842
- Remick, 1993, Comparison of fluoxetine and desipramine in depressed outpatients, Current Therapeutic Research, Clinical & Experimental, 53, 457, 10.1016/S0011-393X(05)80653-8 · DOI
- Remick, 1994, Comparison of fluvoxamine and amitriptyline in depressed outpatients, Current Therapeutic Research, Clinical & Experimental, 55, 243, 10.1016/S0011-393X(05)80168-7 · DOI
- Robertson, 1994, A double-blind controlled comparison of fluoxetine and lofepramine in major depressive illness, Journal of Psychopharmacology, 8, 98, 10.1177/026988119400800205 · DOI
- Ropert, 1989, Fluoxetine versus clomipramine in major depressive disorders, International Clinical Psychopharmacology, 4, 89
- Roth, 1990, A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression, Progress in Neuro-Psychopharmacology & Biological Psychiatry, 14, 929, 10.1016/0278-5846(90)90078-U · DOI
- Shaw, 1986, A comparison of the antidepressant action of citalopram and amitriptyline, British Journal of Psychiatry, 149, 515, 10.1192/bjp.149.4.515 · DOI · Paper page
- Shrivastava, 1992, A double blind comparison of paroxetine, imipramine and placebo in major depression, Journal of Clinical Psychiatry, 53, 48
- 1988, A double-blind multi-centre trial of fluoxetine and dothiepin in major depressive illness, International Clinical Psychopharmacology, 3, 75, 10.1097/00004850-198801000-00006 · DOI
- Stark, 1985, A review of multicenter controlled studies of fluoxetine vs imipramine and placebo in outpatients with major depressive disorder, Journal of Clinical Psychiatry, 46, 53
- Stott, 1993, Depression and associated anxiety in primary care: a double-blind comparison of paroxetine and amitriptyline, European Neuropsychopharmacology, 3, 324, 10.1016/0924-977X(93)90100-Z · DOI
- Stratta, 1991, A double blind parallel study comparing fluoxetine with imipramine in the treatment of atypical depression, International Clinical Psychopharmacology, 6, 193, 10.1097/00004850-199100630-00007 · DOI
- Stuppaek, 1994, A multicentre double-blind trial of paroxetine versus amitriptyline in depressed inpatients, Journal of Clinical Psychopharmacology, 14, 241
- Szegedi, 1997, Response to treatment in minor and major depression: results of a double-blind comparative study with paroxetine and maprotiline. J-Affect-Disord, Journal of Affective Disorders, 45, 167, 10.1016/S0165-0327(97)00072-4 · DOI
- Tamminen, 1989, A double-blind parallel study to compare fluoxetine with doxepin in the treatment of major depressive disorders, International Clinical Psychopharmacology, 4, 51
- Thompson, 1994, Management of depression in real-life settings: knowledge gained from large-scale clinical trials, International Clinical Psychopharmacology, 9, 21, 10.1097/00004850-199406003-00004 · DOI
- Thompson, 1991, Sertraline in a primary care setting, 863
- Timmerman, 1987, A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients, International Clinical Psychopharmacology, 2, 239, 10.1097/00004850-198707000-00006 · DOI
- Upward, 1988, Comparative effects of fluoxetine and amitriptyline on cardiac function, British Journal of Clinical Pharmacology, 26, 399, 10.1111/j.1365-2125.1988.tb03397.x · DOI · Paper page
- Young, 1987, A controlled comparison of fluoxetine and amitriptyline in depressed outpatients, British Journal of Psychiatry, 151, 337, 10.1192/bjp.151.3.337 · DOI · Paper page
- Guy, 1984, A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression, Psychopharmacology Bulletin, 20, 73
- Keller, 1995, Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community, Psychopharmacology Bulletin, 31, 205
- Loeb, 1989, Fluoxetine versus imipramine, International Clinical Psychopharmacology, 4, 75
- Reimherr, 1984, Characteristics or responders to fluoxetine, Psychopharmacology Bulletin, 20, 70
- Simon, 1998, Should anxiety and insomnia influence antidepressant selection: a randomised comparison of fluoxetine and imipramine, Journal of Clinical Psychiatry, 59, 49, 10.4088/JCP.v59n0202 · DOI · Paper page
- Suleman, 1997, Fluoxetine and moclobemide versus amitriptyline in major depression: A single blind randomized clinical trial in Zimbabwe, Central African Journal of Medicine, 43, 38
- Anderson, 1995, Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: A meta-analysis, BMJ, 310, 1433, 10.1136/bmj.310.6992.1433 · DOI · Paper page
- 1980, Diagnostic and Statistical Manual of Mental Disorders (DSM III)
- 1994, Diagnostic and Statistical Manual of Mental Disorders (DSM IV)
- Barbui, 2000, Does placebo help establish equivalence in trials of new antidepressants?, European Psychiatry, 15, 268, 10.1016/S0924-9338(00)00233-9 · DOI
- Boyer, 1993, The financial implications of starting treatment with a selective serotonin reuptake inhibitor or tricyclic antidepressant in drug-naive depressed patients, 65
- Broadhead, 1992, Depression, disability days, and days lost from work in a prospective epidemiological survey, JAMA, 264, 2524, 10.1001/jama.1990.03450190056028 · DOI · Paper page
- 1997, Selective serotonin reuptake inhibitors (SSRIs) for major depression. Part I. Evaluation of the clinical literature
- 1997, Selective serotonin reuptake inhibitors (SSRIs) for major depression. Part II. The cost-effectiveness of SSRIs in the treatment of depression
- DerSimonian, 1986, Meta-analysis in clinical trials, Controlled Clinical Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
- Anonymous, 1993, Selective serotonin reuptake inhibitors for depression, Drug and Therapeutic Bulletin, 31, 57, 10.1136/dtb.31.15.57 · doi:10.1136/dtb.31.15.57
- Dunn, 1999, Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines, Journal of Psychopharmacology, 13, 136, 10.1177/026988119901300204 · DOI · Paper page
- Effective Health Care The treatment of depression in primary health care Effective Health Care Bulletin 1993
- Feighner, 1972, Diagnostic criteria for use in psychiatric research, Archives of General Psychiatry, 26, 57, 10.1001/archpsyc.1972.01750190059011 · DOI · Paper page
- Ganguli, 1997, Antidepressant use over time in a rural older adult population: the MoVIES Project, Journal of the American Geriatric Society, 45, 1501, 10.1111/j.1532-5415.1997.tb03202.x · DOI
- Garattini, 1998, Antidepressant agents: from tricyclics to serotonin uptake inhibitors, Psychological Medicine, 28, 1169, 10.1017/S0033291798007090 · doi:10.1017/s0033291798007090
- Goldberg, 1992, Common mental disorders: A biopsychological approach
- Henry, 1987, The risk-benefit assessment of antidepressant drugs, Medical Toxicology, 2, 445, 10.1007/BF03259878 · DOI
- Hotopf, 1996, Are SSRI a cost effective alternative to tricyclics?, British Journal of Psychiatry, 168, 404, 10.1192/bjp.168.4.404 · DOI · Paper page
- Hotopf, 1997, Discontinuation rates of SSRI and tricyclic antidepressants: A meta-analysis and investigation of heterogeneity, British Journal of Psychiatry, 170, 120, 10.1192/bjp.170.2.120 · DOI · Paper page
- Isacsson, 1999, Selective serotonin reuptake inhibtors have broadened the utilisation of antidepressant treatment in accordance with recommendations, Journal of Affective Disorders, 53, 15, 10.1016/S0165-0327(98)00083-4 · DOI
- Isometsa, 1998, Inadequate dosaging in general practice of tricyclic vs other antidepressants for depression, Acta Psychiatrica Scandinavica, 98, 451, 10.1111/j.1600-0447.1998.tb10118.x · DOI
- Jonsson, 1984, What price for depression? The cost of depression and the cost-effectiveness of pharmacological treatments, British Journal of Psychiatry, 164, 665, 10.1192/bjp.164.5.665 · DOI · Paper page
- Pen, 1994, The cost of treatment dropout in depression. A cost benefit analysis of fluoxetine vs tricyclics, Journal of Affective Disorders, 31, 1, 10.1016/0165-0327(94)90122-8 · DOI
- Montgomery, 1994, Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates, International Clinical Psychopharmacology, 9, 47, 10.1097/00004850-199400910-00008 · DOI · Paper page
- Paykel, 1989, The background: extent and nature of the disorder, 3
- Simon, 1996, Initial Antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants, JAMA, 275, 1897, 10.1001/jama.1996.03530480039038 · DOI · Paper page
- Spitzer, 1977, Research Diagnostic Criteria (RDC) for a selected group of functional disorders
- 1974, International Classification of Diseases
- Woods, 1997, Cost-effectiveness of newer antidepressants, Current Opinion in Psychiatry, 10, 95, 10.1097/00001504-199703000-00007 · DOI
Cited by
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Fergusson, D., Doucette, S., Glass, K. C., Shapiro, S., Healy, D., Hebert, P., & Hutton, B. (2005) · BMJ · doi:10.1136/bmj.330.7488.396 · Cited by 510
Chisholm, D., Sanderson, K., Ayuso-Mateos, J. L., & Saxena, S. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.5.393 · Cited by 366
Sertraline versus other antidepressive agents for depression
Cipriani, A., La Ferla, T., Furukawa, T. A., Signoretti, A., Nakagawa, A., Churchill, R., McGuire, H., & Barbui, C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006117.pub4 · Cited by 299
Self-citationKaltenthaler, E., Sutcliffe, P., Parry, G., Beverley, C., Rees, A., & Ferriter, M. (2008) · Psychological Medicine · doi:10.1017/s0033291707002607 · Cited by 267
Metadata
- Authors
- Barbui, C., Hotopf, M., Freemantle, N., Boynton, J., Churchill, R., Eccles, M., Geddes, J., Hardy, R., Lewis, G., & Mason, J.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2006-07-19
- Issue
- 3
- Pages
- CD002791-CD002791
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1939358643
- Cited by
- 47
- References
- 17
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). https://app.cochat.ai/papers/10.1002/14651858.cd002791.pub2
- The paper
- Barbui, C., Hotopf, M., Freemantle, N., Boynton, J., Churchill, R., Eccles, M., Geddes, J., Hardy, R., Lewis, G., & Mason, J. (2006). Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd002791.pub2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.